Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| BioCardia, Inc.BCDA;BCDAW · Entity 7752 | Director | September 30, 2020 | October 09, 2020 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
BioCardia, Inc.
Report date September 30, 2020 · Filed October 09, 2020
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 40,644 |
Reported balance
After 2020-09-30 transaction · row 1
1 source rowRow 1 · 2020-09-30 · Grant · Acquired 2,968 · Balance 40,644 F1: The award relates to vested restricted stock units ("RSUs") granted September 30, 2020, each of which represents a contingent right to receive one share of the Issuer's common stock, but for which delivery of common stock will occur the earliest of (1) the two (2) year anniversary of the grant date; (3) the Reporting Person's separation from service; (3) a change in control, as defined in the Issuer's 2016 Equity Incentive Plan; or (4) the Reporting Person's death. |
Filing footnotes · ownership attribution and instrument terms
F1: The award relates to vested restricted stock units ("RSUs") granted September 30, 2020, each of which represents a contingent right to receive one share of the Issuer's common stock, but for which delivery of common stock will occur the earliest of (1) the two (2) year anniversary of the grant date; (3) the Reporting Person's separation from service; (3) a change in control, as defined in the Issuer's 2016 Equity Incentive Plan; or (4) the Reporting Person's death.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 30, 2020 Filed Oct 9, 2020 23:17 UTC | BioCardia, Inc. BCDA;BCDAW · Entity 7752 | GrantCommon Stock | 2,968 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-20-021025 · rdgdoc.xml · nonDerivative · entry 1 FERNANDEZ FERNANDO L · CIK 0001214346 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,644 F1 · shares: The award relates to vested restricted stock units ("RSUs") granted September 30, 2020, each of which represents a contingent right to receive one share of the Issuer's common stock, but for which delivery of common stock will occur the earliest of (1) the two (2) year anniversary of the grant date; (3) the Reporting Person's separation from service; (3) a change in control, as defined in the Issuer's 2016 Equity Incentive Plan; or (4) the Reporting Person's death. Read SEC document |
| June 30, 2020 Filed Jul 1, 2020 20:51 UTC | BioCardia, Inc. BCDA;BCDAW · Entity 7752 | GrantCommon Stock | 2,968 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-20-014380 · rdgdoc.xml · nonDerivative · entry 1 FERNANDEZ FERNANDO L · CIK 0001214346 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,676 F1 · shares: The award relates to vested restricted stock units ("RSUs") granted June 30, 2020, each of which represents a contingent right to receive one share of the Issuer's common stock, but for which delivery of common stock will occur the earliest of (1) the two (2) year anniversary of the grant date; (3) the Reporting Person's separation from service; (3) a change in control, as defined in the Issuer's 2016 Equity Incentive Plan; or (4) the Reporting Person's death. Read SEC document |
| May 08, 2020 Filed May 21, 2020 00:53 UTC | BioCardia, Inc. BCDA;BCDAW · Entity 7752 | GrantCommon Stock | 8,800 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-20-011475 · rdgdoc.xml · nonDerivative · entry 1 FERNANDEZ FERNANDO L · CIK 0001214346 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,708 F1 · shares: The award relates to vested restricted stock units ("RSUs") granted May 8, 2020, each of which represents a contingent right to receive one share of the Issuer's common stock, but for which delivery of common stock will occur the earliest of (1) the two (2) year anniversary of the grant date; (3) the Reporting Person's separation from service; (3) a change in control, as defined in the Issuer's 2016 Equity Incentive Plan; or (4) the Reporting Person's death. Read SEC document |
| April 30, 2020 Filed May 5, 2020 01:33 UTC | BioCardia, Inc. BCDA;BCDAW · Entity 7752 | GrantCommon Stock | 2,968 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-20-009338 · rdgdoc.xml · nonDerivative · entry 2 FERNANDEZ FERNANDO L · CIK 0001214346 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,908 F1 · shares: The award relates to vested restricted stock units ("RSUs") granted April 30, 2020, each of which represents a contingent right to receive one share of the Issuer's common stock, but for which delivery of common stock will occur the earliest of (i) two years from the date of grant, (ii) the date the director ceases to be a service provider, or (iii) such other date as the administrator determines under the Issuer's 2016 Equity Incentive Plan. Read SEC document |
| April 30, 2020 Filed May 5, 2020 01:33 UTC | BioCardia, Inc. BCDA;BCDAW · Entity 7752 | GrantCommon Stock | 16,625 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-20-009338 · rdgdoc.xml · nonDerivative · entry 1 FERNANDEZ FERNANDO L · CIK 0001214346 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,940 F1 · shares: The award relates to vested restricted stock units ("RSUs") granted April 30, 2020, each of which represents a contingent right to receive one share of the Issuer's common stock, but for which delivery of common stock will occur the earliest of (i) two years from the date of grant, (ii) the date the director ceases to be a service provider, or (iii) such other date as the administrator determines under the Issuer's 2016 Equity Incentive Plan. Read SEC document |
| January 13, 2020 Filed Feb 11, 2020 02:19 UTC | BioCardia, Inc. BCDA;BCDAW · Entity 7752 | Exercise / conversionRestricted Stock Units · Derivative | 567 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-20-002226 · rdgdoc.xml · derivative · entry 2 FERNANDEZ FERNANDO L · CIK 0001214346 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 567 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. F4 · derivative.exercise_date: On January 13, 2017, the reporting person was granted 184,000 RSUs (1,703 after the 1-for-9 reverse stock split effective May 7, 2019 and the 1-for-12 reverse split effective November 2, 2017), of which the final 567 RSUs remaining under the grant vested on January 13, 2020. The common stock into which such vested RSUs converted on January 13, 2020 is reported on Table I of this Form 4. F4 · derivative.expiration_date: On January 13, 2017, the reporting person was granted 184,000 RSUs (1,703 after the 1-for-9 reverse stock split effective May 7, 2019 and the 1-for-12 reverse split effective November 2, 2017), of which the final 567 RSUs remaining under the grant vested on January 13, 2020. The common stock into which such vested RSUs converted on January 13, 2020 is reported on Table I of this Form 4. Read SEC document |
| January 13, 2020 Filed Feb 11, 2020 02:19 UTC | BioCardia, Inc. BCDA;BCDAW · Entity 7752 | Exercise / conversionCommon Stock | 567 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001437749-20-002226 · rdgdoc.xml · nonDerivative · entry 1 FERNANDEZ FERNANDO L · CIK 0001214346 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,315 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Represents the conversion upon vesting of restricted stock units ("RSUs") into common stock. On January 13, 2017, the reporting person was granted 184,000 RSUs (1,703 after the 1-for-9 reverse stock split effective May 7, 2019 and the 1-for-12 reverse split effective November 2, 2017) that were previously reported on Table II of Form 4, which form was filed with the Securities and Exchange Commission (the "SEC") on January 18, 2017. F2 · price: The converted RSU corresponds to a 1:1 common stock issuance. Read SEC document |
| July 26, 2019 Filed Aug 23, 2019 10:04 UTC | BioCardia, Inc. BCDA;BCDAW · Entity 7752 | Exercise / conversionRestricted Stock Units · Derivative | 3,594 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001437749-19-017324 · rdgdoc.xml · derivative · entry 4 FERNANDEZ FERNANDO L · CIK 0001214346 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 567 Underlying: Common Stock · 3,594 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. F6 · derivative.exercise_date: On July 26, 2018, the reporting person was granted 32,353 RSUs (3,594 after the 1-for-9 reverse split effective May 7, 2019), which vested on July 26, 2019. The common stock into which such vested RSUs converted on July 26, 2019 is reported on Table I of this Form 4. F6 · derivative.expiration_date: On July 26, 2018, the reporting person was granted 32,353 RSUs (3,594 after the 1-for-9 reverse split effective May 7, 2019), which vested on July 26, 2019. The common stock into which such vested RSUs converted on July 26, 2019 is reported on Table I of this Form 4. Read SEC document |
| July 26, 2019 Filed Aug 23, 2019 10:04 UTC | BioCardia, Inc. BCDA;BCDAW · Entity 7752 | Exercise / conversionCommon Stock | 3,594 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-19-017324 · rdgdoc.xml · nonDerivative · entry 2 FERNANDEZ FERNANDO L · CIK 0001214346 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,748 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · kind: Represents the conversion upon vesting of RSUs into common stock. On July 26, 2018, the reporting person was granted 32,353 RSUs (3,594 after the 1-for-9 reverse split effective May 7, 2019) that were previously reported on Table II of Form 4, which form was filed with the SEC on September 26, 2018. F3 · price: The converted RSU corresponds to a 1:1 common stock issuance. Read SEC document |
| January 13, 2019 Filed Aug 23, 2019 10:04 UTC | BioCardia, Inc. BCDA;BCDAW · Entity 7752 | Exercise / conversionRestricted Stock Units · Derivative | 567 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001437749-19-017324 · rdgdoc.xml · derivative · entry 3 FERNANDEZ FERNANDO L · CIK 0001214346 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,161 Underlying: Common Stock · 567 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. F5 · derivative.exercise_date: On January 13, 2017, the reporting person was granted 184,000 RSUs (1,703 after the 1-for-9 reverse stock split effective May 7, 2019 and the 1-for-12 reverse split effective November 2, 2017), of which 567 vested on January 13, 2019. The common stock into which such vested RSUs converted on January 13, 2019 is reported on Table I of this Form 4. The remaining RSUs will vest on the third one-year anniversary of the grant date, subject to the Reporting Person continuing as a service provider through such date. F5 · derivative.expiration_date: On January 13, 2017, the reporting person was granted 184,000 RSUs (1,703 after the 1-for-9 reverse stock split effective May 7, 2019 and the 1-for-12 reverse split effective November 2, 2017), of which 567 vested on January 13, 2019. The common stock into which such vested RSUs converted on January 13, 2019 is reported on Table I of this Form 4. The remaining RSUs will vest on the third one-year anniversary of the grant date, subject to the Reporting Person continuing as a service provider through such date. Read SEC document |
| January 13, 2019 Filed Aug 23, 2019 10:04 UTC | BioCardia, Inc. BCDA;BCDAW · Entity 7752 | Exercise / conversionCommon Stock | 567 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-19-017324 · rdgdoc.xml · nonDerivative · entry 1 FERNANDEZ FERNANDO L · CIK 0001214346 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,154 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Represents the conversion upon vesting of restricted stock units ("RSUs") into common stock. On January 13, 2017, the reporting person was granted 184,000 RSUs (1,703 after the 1-for-9 reverse stock split effective May 7, 2019 and the 1-for-12 reverse split effective November 2, 2017) that were previously reported on Table II of Form 4, which form was filed with the Securities and Exchange Commission (the "SEC") on January 18, 2017. F3 · price: The converted RSU corresponds to a 1:1 common stock issuance. Read SEC document |
| July 26, 2018 Filed Sep 27, 2018 01:16 UTC | BioCardia, Inc. BCDA · Entity 7752 | GrantRestricted Stock Units · Derivative | 32,353 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001437749-18-017506 · rdgdoc.xml · derivative · entry 5 FERNANDEZ FERNANDO L · CIK 0001214346 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,353 Underlying: Common Stock · 32,353 shares Expires not disclosed F5 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. F10 · derivative.exercise_date: The restricted stock units vest as to one hundred percent of the shares on July 26, 2019, subject to the Reporting Person continuing as a service provider through such date. Vested shares will be delivered to the Reporting Person on July 26, 2019. F10 · derivative.expiration_date: The restricted stock units vest as to one hundred percent of the shares on July 26, 2019, subject to the Reporting Person continuing as a service provider through such date. Vested shares will be delivered to the Reporting Person on July 26, 2019. Read SEC document |
| June 15, 2018 Filed Sep 27, 2018 01:16 UTC | BioCardia, Inc. BCDA · Entity 7752 | Exercise / conversionRestricted Stock Units · Derivative | 9,166 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001437749-18-017506 · rdgdoc.xml · derivative · entry 4 FERNANDEZ FERNANDO L · CIK 0001214346 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 0 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Each RSU is the economic equivalent of one share of BioCardia, Inc. common stock. The closing price of BCDA on June 15, 2018 was $1.40 per share. F9 · derivative.exercise_date: On June 15, 2017, the reporting person was granted 110,000 RSUs (9,166 after the 12-to-1 reverse split effective November 2, 2017), which vested on June 15, 2018. The common stock into which such vested RSUs converted on June 15, 2018 is reported on Table I of this Form 4. F9 · derivative.expiration_date: On June 15, 2017, the reporting person was granted 110,000 RSUs (9,166 after the 12-to-1 reverse split effective November 2, 2017), which vested on June 15, 2018. The common stock into which such vested RSUs converted on June 15, 2018 is reported on Table I of this Form 4. Read SEC document |
| June 15, 2018 Filed Sep 27, 2018 01:16 UTC | BioCardia, Inc. BCDA · Entity 7752 | Exercise / conversionCommon Stock | 9,166 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-18-017506 · rdgdoc.xml · nonDerivative · entry 2 FERNANDEZ FERNANDO L · CIK 0001214346 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,277 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · kind: Represents the conversion upon vesting of RSUs into common stock. On June 15, 2017, the reporting person was granted 110,000 RSUs (9,166 after the 12-to-1 reverse split effective November 2, 2017) that were previously reported on Table II of Form 4, which form was filed with the SEC on August 25, 2017. F7 · balance_after: The converted RSU corresponds to a 1:1 common stock issuance. Read SEC document |
| January 13, 2018 Filed Sep 27, 2018 01:16 UTC | BioCardia, Inc. BCDA · Entity 7752 | Exercise / conversionRestricted Stock Units · Derivative | 5,111 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001437749-18-017506 · rdgdoc.xml · derivative · entry 3 FERNANDEZ FERNANDO L · CIK 0001214346 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,222 Underlying: Common Stock · 10,222 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each RSU is the economic equivalent of one share of BioCardia, Inc. common stock. The closing price of BCDA on January 12, 2018 was $2.95 per share. F8 · derivative.exercise_date: On January 13, 2017, the reporting person was granted 184,000 RSUs (15,333 after the 12-to-1 reverse split effective November 2, 2017), of which 5,111 vested on January 13, 2018. The common stock into which such vested RSUs converted on January 13, 2018 is reported on Table I of this Form 4. The remaining RSUs will continue to vest on the second and third one-year anniversary of the grant date, subject to the Reporting Person continuing as a service provider through each such date. F8 · derivative.expiration_date: On January 13, 2017, the reporting person was granted 184,000 RSUs (15,333 after the 12-to-1 reverse split effective November 2, 2017), of which 5,111 vested on January 13, 2018. The common stock into which such vested RSUs converted on January 13, 2018 is reported on Table I of this Form 4. The remaining RSUs will continue to vest on the second and third one-year anniversary of the grant date, subject to the Reporting Person continuing as a service provider through each such date. Read SEC document |
| January 13, 2018 Filed Sep 27, 2018 01:16 UTC | BioCardia, Inc. BCDA · Entity 7752 | Exercise / conversionCommon Stock | 5,111 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-18-017506 · rdgdoc.xml · nonDerivative · entry 1 FERNANDEZ FERNANDO L · CIK 0001214346 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,111 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Represents the conversion upon vesting of restricted stock units ("RSUs") into common stock. On January 13, 2017, the reporting person was granted 184,000 RSUs (15,333 after the 12-to-1 reverse split effective November 2, 2017) that were previously reported on Table II of Form 4, which form was filed with the Securities and Exchange Commission (the "SEC") on January 18, 2017. F6 · balance_after: The converted RSU corresponds to a 1:1 common stock issuance. Read SEC document |
| June 15, 2017 Filed Aug 25, 2017 21:48 UTC | BioCardia, Inc. BCDA · Entity 7752 | GrantRestricted Stock Units · Derivative | 110,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-17-015347 · rdgdoc.xml · derivative · entry 1 FERNANDEZ FERNANDO L · CIK 0001214346 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 110,000 Underlying: Common Stock · 110,000 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. F2 · derivative.exercise_date: The restricted stock units vest and become exercisable as to one hundred percent of the shares on June 15, 2018, subject to the Reporting Person continuing as a service provider through such date F2 · derivative.expiration_date: The restricted stock units vest and become exercisable as to one hundred percent of the shares on June 15, 2018, subject to the Reporting Person continuing as a service provider through such date Read SEC document |
| January 13, 2017 Filed Jan 18, 2017 23:39 UTC | BioCardia, Inc. BCDA · Entity 7752 | GrantRestricted Stock Units · Derivative | 184,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-17-000796 · rdgdoc.xml · derivative · entry 1 FERNANDEZ FERNANDO L · CIK 0001214346 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 184,000 Underlying: Common Stock · 184,000 shares Expires 2020-01-13 F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. F2 · derivative.exercise_date: The restricted stock units vest and become exercisable as to one-third of the shares on January 13, 2018 and each one-year anniversary thereafter, subject to the Reporting Person continuing as a service provider through each such date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.